DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.

The sharp upward movement is driven by the company's better-than-expected fourth-quarter financial results and an optimistic profit forecast for 2026 that exceeded analyst estimates. DaVita reported adjusted earnings per share of $3.40 on revenue of $3.62 billion for Q4 2025, surpassing expectations. Furthermore, the company provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, signaling strong confidence in future performance fueled by steady demand for its kidney dialysis services, higher reimbursement rates, and recovery from prior operational challenges.

Adding to the positive sentiment, DaVita announced a strategic minority investment in home-care provider Elara Caring. The partnership aims to co-develop a kidney-specific home-based care model, which is expected to reduce hospitalizations and lower costs, supporting the company's growth initiatives in personalized patient care.